Bio-Labs is proud to have received the “Best Pharmaceutical Entity 2022” award at the Rawalpindi Chamber of Commerce & Industry’s Annual Achievement Awards held in Bangkok on August 19, 2022 presented by the Thailand Deputy Prime Minister’s office. Our pursuit for excellence in pharmaceuticals shall continue with the same zeal and spirit going forward.
Category: News
Bio-Labs Signed MOU with N-ovative Health Technologies (NHT), for cardiac stents & catheters
Bio-Labs (Pvt.) Ltd is proud and excited to sign the Memorandum of Understanding with N-ovative Health Technologies (NHT), an initiative of NUST, to bring its unique and advanced cardiac stents & catheters to the international markets. The Managing Director of Bio-Labs Mr. Usman Shaukat and CEO of NHT Mr. Dr. Murtaza Najabat Ali have signed the MOU. This agreement is a nod to Bio-Labs’ burgeoning consumer trust and strict adherence towards maintaining and raising quality standards. Through Bio-Labs’ expansive network of local and international audiences and NHT’s quality manufacturing, the company hopes to make a meaningful impact
Bio-Labs – Donated medicines to Sri Lanka
In lieu of the severe drug shortages in Sri Lanka owing to the ongoing economic crisis, Bio-Labs was heart in hands to provide relief to the Sri Lankan brothers and sisters when reached out to by the Srilanka High commission Islamabad. The company responded by giving medicinal donations to Sri Lanka in an effort to uplift health standards and save lives. The consignment was received by the Dr. Anar Hamdani on behalf of the Ministry of Health, Sri Lanka. Health anywhere in the world is precious, and Bio-Labs was honored to play its small part in assisting the Sri Lankan community in their time of need. Health and prosperity for all.
Bio-Labs successfully launched Qualey (Quetiapine Fumarate) in it’s Psychiatry Division
Bio-Labs added a new product to the psychiatry division, Qualey (Quetiapine Fumarate). Bio-Labs is pleased and honored to help people take a step “Towards the Peak of Stability” through this product.
Around 50 million people struggle with mental disorders in Pakistan, and Qualey is their solution. It’s an FDA approved atypical antipsychotic that is ideal for treating Schizophrenia and Bipolar Disorder. In addition, it offers high efficacy with lesser side effects than other atypical antipsychotics.
